Several pyrrolidine-containing analogues of poststatin were synthesized and examined for their inhibitory activity against prolyl endopeptidase and cathepsin B in vitro. Replacement of the postine residue with 2-oxo-2-(2-pyrrolidinyl)acetic acid increased the selectivity and inhibitory activity against 
Poststatin (PST), a new inhibitor of prolyl endopeptidase (PEP), with a structure of L-Val-L-Val-(S)-3-amino-2-oxovaleryl-D-Leu-L-Val, has been isolated from a culture filtrate of Streptomyces viridochromogenes MH534-30F31~3).
In the preceding paper4), we synthesized thirty analogues of PST containing a /?-substituted-/?-amino-ocoxopropionic acid residue and described the relationship between structure and the inhibitory activity to some serine and cysteine endopeptidases. Low molecular weight inhibitors of PEP have been widely studied. Proline containing chloromethyl ketone derivatives or peptide aldehyde analogues such as benzyloxycarbonyl (abbreviatedasZ)-Gly-Pro-CH2C1 or Z-Pro-prolinal weredesigned, synthesized, and found to show stronginhibitory activity toPEPby Yoshimoto in 19775) and Wilk in 19836) . Recently, thiazolidine derivatives suchas Z-thiopro-thiazolidine and pyrrolidine derivatives such asl -(7V-(4-phenylbutyryl)-Pro)-pyrrolidine werereported asanother typeinhibitor ofPEPby Tsuru in 19887) and Saito in19918). In comparison withthese structure, PSTincludeda unique jS-amino-a-oxocarboxylic acidresidue init and had another two aminoacidresidues at the P^and P'2 positions. The latter suggests it is possibletomodify orreplace with suitable structures the subsite ofeach In order to increase the selectivity for PEPwe replaced 2-oxo-2-(2-pyrrolidinyl)acetic acid for 3-amino-2-oxovaleric acid (named as postine, abbreviated as Pos)
as the derivative of /?-amino-a-oxocarboxylic acid. The synthesis of (RS>2-hydroxy-2-((S)-2-pyrrolidinyl)acetic acid was shown in Scheme 1.
In this paper, we report the synthesis of a newtype of pyrrolidine derivatives as potential inhibitors of PEP, and inhibitory activity against PEP as contrasted with cathepsin B in vitro. 901 
Results and Discussion
The results obtained are summarized in Table 1 creased the inhibitory activity against PEPsignificantly, and markedly decreased the inhibitory activity against cathepsin B. The N-and C-terminal protected derivatives of pyrrolidine analogue 2 (No. 4) also showed stronger inhibitory activity against PEPthan Pos-containing analogue (No. 3). Therefore, pyrrolidine ring at the Px Table 1 . Relationship between structure and endopeptidase inhibitory activities. Natural poststatin. These compounds were described in the previous paper4).
Compounds in parentheses are also listed earlier in the is important for PEP inhibition.
As reported in our previous paper4), replacement of the P2 and P3 of poststatin by Z-Phe increased the inhibitory activity against PEP. Therefore pyrrolidine derivatives containing Z-Phe at P2 and P3 were synthesized. The Pos-containing analogue (No. 5) , in which the C-terminal of P2 at active analogue 6 was esteriflcated, decreased the inhibitory activity against PEP. The Pos-containing analogue (No. 8), in which P2 residue was deleted from active analogue 6 or 7, also showed weak inhibitory activity. In contrast with Poscontaining analogues, the pyrrolidine analogues (No. 9 and 10) showed about the same strong inhibitory activity as analogue ll in spite of the modification at P3 or P2. Therefore, the influence of P3 or P2 is smaller in pyrrolidine-containing peptides than in Pos-containing peptides.
To estimate the effect of the stereochemistry at P'l5 we synthesized L-Leu analogues at P^(No. 14 and 15). In the Pos-containing analogues (No. 12 and 13), replacement of D-Leu by L-Leu decreased the inhibitory activity against PEP significantly.
In contrast, the pyrrolidine analogues (No. 14 and 15) showed strong inhibitory activity against PEP as well as analogues 10 and ll in which P\ positions were D-Leu. Therefore, the d configuration at the Pi is not essential for pyrrolidine-containing peptides. Analogues, in which P^of analogues 10 and ll were replaced by were synthesized. Moreover, analogue 20, in which P'x was not an amino acid residue but a cyclohexylamine componentwasprepared. All these analogues showed strong inhibitory activity against PEP, and among them analogue 18 showed about 46 times as much active as natural PST (No. 1) . Therefore, the contribution of Pî n the pyrrolidine-containing peptides is small though Pî n the Pos-containing peptides was important. In the Pos-containing peptides, deletion of the amino acid residue at P2 markedly decreased the inhibitory activity against PEP (No. 21). Pyrrolidine analogues 24, 25, 27~29, in which amino acid residues at P2 were deleted showed lower inhibitory activity against PEP than the analogues having an amino acid residue at P2 (No. 9, 22, 23, 10 and 26) . Some of the analogues lacking the amino acid residue at P2 maintained about the same inhibitory activity as natural PST. Among these short pyrrolidine analogues, analogue 24 was about 1.8 times more potent than natural PST in its inhibitory activity.
Therefore, the presence of one amino acid residue at P2 is preferable for strong inhibition against PEP, but 
Boc-H.ProCO
To a suspension of LiAlH4 (10.62g, 279.8mmol) in dry THF (300ml) was added a solution of31 (114.5g, 349.7mmol) in dry THF (120ml) over a period of 1 hour keeping the temperature at -15 to -20°C in an argon atmosphere. After standing for another 1.5 hours at the same temperature, the reaction mixture was cooled to VOL.49 NO.9 THE JOURNAL OF ANTIBIOTICS -60°C and the mixture was diluted with THF (100ml). 3n HC1(900ml) was added slowly at the temperature below -40°C. After removal of A1(OH)3 by filtration, the filtrate was concentrated. The aqueous layer was extracted twice with EtOAc (300ml). The combined organic layer was washed with saturated aq NaHCO3 (300ml), saturated aq NaCl (300mix2) and dried (Na2SO4). Evaporation of the solvent gave an oil of crude Z-L-prolinal (56.7 g). To the Z-L-prolinal in EtOAc (78 ml) was added aq solution ofNa2S2O5 (95%; 48.64g, 243.1 mmol) in water (78 ml) and the mixture was stirring overnight. The aqueous layer was separated, and added water to 300ml. To the solution ofNaHSO3adduct was added EtOAc (300ml) and aq solution ofNaCN (1 1.91 g, 243.0 mmol) in water (80 ml) in an ice bath. After standing for 30minutes at 0°C, the reaction mixture was stirred for 4hours at room temperature. The organic layer was separated and washed twice with saturated aq NaCl (180 ml) and dried (Na2SO4). Evaporation of the solvent 
Crude 36 was obtained, in a manner similar to that described in the preparation of 35, by coupling reaction ofTFA salt ofdeprotected 35 (1.290 
Crude 37 was obtained, in a manner similar to that described in the preparation of 35, by coupling reaction of TFA salt of deprotected 36 (0.729mmol) with Z-Val (201.4mg, 0.802mmol 
A mixture of 37 (386.8mg, 0.496 mmol), pyridinium trifluoroacetate (48.6mg, 0.252mol), EDC HC1 (287.3 mg, 1.499 mmol), anhydrous DMSO(4.0 ml) was stirred at room temperature for 23 hours. The reaction mixture was diluted with EtOAc (40ml) and washed with water (30ml), and dried (Na2SO4 
To 
Acid (Z-H2ProCO, 38) To the cyanohydrin (32) prepared from 31 (20.07g, 61.3mmol) as described for the preparation of 30 was added 12n HC1 (45 ml) and dioxane (45 ml), and refluxed for 6 hours. After evaporation of the solvent, the residue (6.36g) was dissolved in distilled water and deionized through a column of strong acidic ion-exchange resin A mixture of 33 (1.60g, ll.0mmol), benzyl S-4,6-dimethylpyrimidin-2-ylthiocarbonate (3.63 g, 1 3.2 mmol), water (6ml), dioxane (6ml) and triethylamine (2.30ml, 16.5 mmol) was stirred for 3 hours at room temperature.
To a reaction mixture was added water (16ml), and unreacted carbonate was extracted twice with EtOAc (each 20ml). The aqueous layer was cooled to 0°C and adjusted to pH 2 by addition ofa 3n HC1, and extracted with EtOAc (once 16ml, twice 8ml). The combined organic layer was washed thrice with 1n HC1(each 10ml), and twice with saturated aq NaCl (each 10ml) and dried (Na2SO4 
To a solution of39 (309.6mg, 0.690mmol) in MeOH (10ml) was added palladium-black catalyst (13.4mg).
The mixture was hydrogenated at roomtemperature in a hydrogen atmosphere for 24hours. (2.0 ml) was stirred at room temperature for 9 hours. The reaction mixture was diluted with EtOAc(25ml), and the undissolved material was removed by filtratio'n. The filtrate was washed with water (20ml), and dried (Na2SO4). After evaporation of the solvent, the product was purified by silica gel column chromatography with +, 552, 508, 474, 444, 418, 257, 91, 70, 57; XHNMR (270MHz, CDC13) Postproline cleaving enzyme. Identification as serine protease using active site specific inhibitors. Biochemistry
